1
|
Maurya A, Agrawal A. Recent Advancement in Bioactive Chalcone Hybrids as Potential Antimicrobial Agents in Medicinal Chemistry. Mini Rev Med Chem 2024; 24:176-195. [PMID: 37497710 DOI: 10.2174/1389557523666230727102606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 06/08/2023] [Accepted: 06/16/2023] [Indexed: 07/28/2023]
Abstract
Chalcones are flavonoid-related aromatic ketones and enones generated from plants. The chalcones have a wide range of biological activities, such as anti-tumor, calming, and antimicrobial activities. In the present review, we have focused on the recently published original research articles on chalcones as a unique antibacterial framework in medicinal chemistry. Chalcones are structurally diverse moieties and can be split into simple and hybrid chalcones, with both having core pharmacophore 1,3-diaryl-2-propen-1-one. Chalcones are isolated from natural sources and also synthesized by using various methods. Their structure-activity relationship, mechanisms, and list of patents are also summarized in this paper. This review article outlines the currently published antimicrobial chalcone hybrids and suggests that chalcone derivatives may be potential antimicrobial agents in the future.
Collapse
Affiliation(s)
- Anand Maurya
- Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, U.P., 221005, India
| | - Alka Agrawal
- Department of Medicinal Chemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, U.P., 221005, India
| |
Collapse
|
2
|
de Souza AC, Mori M, Sens L, Rocha RF, Tizziani T, de Souza LF, Domeneghini Chiaradia-Delatorre L, Botta M, Nunes RJ, Terenzi H, Menegatti AC. A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia. Bioorg Med Chem Lett 2020; 30:127350. [DOI: 10.1016/j.bmcl.2020.127350] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Revised: 06/08/2020] [Accepted: 06/09/2020] [Indexed: 01/01/2023]
|
3
|
Recent developments of chalcones as potential antibacterial agents in medicinal chemistry. Eur J Med Chem 2020; 187:111980. [DOI: 10.1016/j.ejmech.2019.111980] [Citation(s) in RCA: 68] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2019] [Revised: 12/13/2019] [Accepted: 12/16/2019] [Indexed: 12/31/2022]
|
4
|
Sens L, de Souza ACA, Pacheco LA, Menegatti ACO, Mori M, Mascarello A, Nunes RJ, Terenzi H. Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors. Bioorg Med Chem 2018; 26:5742-5750. [DOI: 10.1016/j.bmc.2018.10.030] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2018] [Revised: 10/01/2018] [Accepted: 10/26/2018] [Indexed: 10/28/2022]
|
5
|
Siqueira JD, Menegatti AC, Terenzi H, Pereira MB, Roman D, Rosso EF, Piquini PC, Iglesias BA, Back DF. Synthesis, characterization and phosphatase inhibitory activity of dioxidovanadium(V) complexes with Schiff base ligands derived from pyridoxal and resorcinol. Polyhedron 2017. [DOI: 10.1016/j.poly.2017.04.004] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
6
|
Martins PGA, Mori M, Chiaradia-Delatorre LD, Menegatti ACO, Mascarello A, Botta B, Benítez J, Gambino D, Terenzi H. Exploring Oxidovanadium(IV) Complexes as YopH Inhibitors: Mechanism of Action and Modeling Studies. ACS Med Chem Lett 2015; 6:1035-40. [PMID: 26617957 PMCID: PMC4641580 DOI: 10.1021/acsmedchemlett.5b00267] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2015] [Accepted: 08/31/2015] [Indexed: 12/13/2022] Open
Abstract
![]()
YopH
tyrosine phosphatase, a virulence factor produced by pathogenic species
of Yersinia, is an attractive drug target. In this
work, three oxidovanadium(IV) complexes were assayed against recombinant
YopH and showed strong inhibition of the enzyme in the nanomolar range.
Molecular modeling indicated that their binding is reinforced by H-bond,
cation−π, and π–π interactions conferring
specificity toward YopH. These complexes are thus interesting lead
molecules for phosphatase inhibitor drug discovery.
Collapse
Affiliation(s)
- Priscila G. A. Martins
- Centro
de Biologia Molecular Estrutural−CEBIME, Universidade Federal de Santa Catarina, Campus Trindade, 88040-900 Florianópolis, Santa Catarina, Brasil
| | - Mattia Mori
- Center
for Life NanoScience@Sapienza, Istituto Italiano di Tecnologia, viale Regina Elena 291, 00161 Roma, Italy
| | - Louise D. Chiaradia-Delatorre
- Centro
de Biologia Molecular Estrutural−CEBIME, Universidade Federal de Santa Catarina, Campus Trindade, 88040-900 Florianópolis, Santa Catarina, Brasil
| | - Angela C. O. Menegatti
- Centro
de Biologia Molecular Estrutural−CEBIME, Universidade Federal de Santa Catarina, Campus Trindade, 88040-900 Florianópolis, Santa Catarina, Brasil
| | - Alessandra Mascarello
- Centro
de Biologia Molecular Estrutural−CEBIME, Universidade Federal de Santa Catarina, Campus Trindade, 88040-900 Florianópolis, Santa Catarina, Brasil
- Dipartimento di Chimica
e Tecnologia del Farmaco, Sapienza, Università di Roma, Piazzale Aldo
Moro 5, 00185 Roma, Italy
| | - Bruno Botta
- Dipartimento di Chimica
e Tecnologia del Farmaco, Sapienza, Università di Roma, Piazzale Aldo
Moro 5, 00185 Roma, Italy
| | - Julio Benítez
- Cátedra de Química Inorgánica,
Facultad de Química, Universidad de la República, Gral. Flores 2124, 11800 Montevideo, Uruguay
| | - Dinorah Gambino
- Cátedra de Química Inorgánica,
Facultad de Química, Universidad de la República, Gral. Flores 2124, 11800 Montevideo, Uruguay
| | - Hernán Terenzi
- Centro
de Biologia Molecular Estrutural−CEBIME, Universidade Federal de Santa Catarina, Campus Trindade, 88040-900 Florianópolis, Santa Catarina, Brasil
| |
Collapse
|
7
|
Abstract
Natural or synthetic chalcones with different substituents have revealed a variety of biological activities that may benefit human health. The underlying mechanisms of action, particularly with respect to the direct cellular targets and the modes of interaction with the targets, have not been rigorously characterized, which imposes challenges to structure-guided rational development of therapeutic agents or chemical probes with acceptable target-selectivity profile. This review summarizes literature evidence on chalcones’ direct molecular targets in the context of their biological activities.
Collapse
Affiliation(s)
- Bo Zhou
- Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, USA
| | - Chengguo Xing
- Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, USA
| |
Collapse
|